Has Rohit Verma, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,919 in general payments to Rohit Verma, MD across 130 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rohit Verma, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rohit Verma, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rohit Verma, MD

Orthopaedic Surgery of the Spine · Great Neck, NYNPI 1013930684

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (34.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 65.0% of it on its own, with 12 other manufacturers making up the rest.

$20,919in general payments, 2019–2025

Across 130 payments — averaging $160.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$14K
Stryker$2K
Geistlich Pharma, North America, Inc.$2K
Medical Device Business Services, Inc.$983
Johnson & Johnson$690
Globus Medical$656
plus $1K from 7 others

$51,211in research payments, 2019–2025

Across 7 payments — averaging $7315.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Surgalign Spine Technologies, Inc.$51K

What the payments were for

Consulting fees$3,21515%
Speaking & faculty fees$7,29035%
Travel & lodging$5,09724%
Food & beverage$5,31725%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	97	$13,607
Stryker	11	$2,232
Geistlich Pharma, North America, Inc.	1	$1,500
Medical Device Business Services, Inc.	5	$983
Johnson & Johnson(2 entities)	2	$690
Globus Medical(2 entities)	5	$656
Baxter Healthcare	2	$500
DJO, LLC	2	$293
Biocomposites Inc	1	$132
Titan Spine, LLC	1	$128
Intrinsic Therapeutics	1	$119
Degen Medical, Inc.	1	$64
Misonix Inc	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CD HORIZON SPINAL SYSTEM$8,542
EVEREST SPINAL SYSTEM$1,797
MAZOR X SYSTEM$1,672
Velys$917
Mazor X Stealth Edition$798
DIVERGENCE-L$458
Excelsius - GPS$428
CMF SPINALOGIC$293
MazorX - Renaissance$279
FLOSEAL$250
Non-Franchise (NOF) - NonProduct$250
BARRICAID ACD (ANNULAR CLOSURE DEVICE)$237
DENALI SPINAL SYSTEM$156
N/A$146
Stimulan$132
nanoLOCK$128
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$116
ADHERUS AUTOSPRAY DURAL SEALANT$109
DURAMATRIX$109
UNID_PASS$101

How this compares

$20,919 in reported general payments places this provider in the 60th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York →

Medicare billing

Part B allowed, 2024

$263,772

Medicare patients

370

Services billed

1,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	171	$4,359
Diclofenac Sodium	100	$2,119
Gabapentin	213	$1,977
Tizanidine Hcl	158	$1,607
Cyclobenzaprine Hcl	134	$1,154
Meloxicam	417	$1,082
Oxycodone Hcl	43	$659
Tramadol Hcl	34	$369
Prednisone	50	$207
Ibuprofen	25	$202
Omeprazole	25	$195
Pregabalin	13	$182
Naproxen	12	$162
Methocarbamol	12	$69

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Great Neck

Hansen YuanSyracuse$31.7M
Frank SchwabNew York$5.1M
Han KimNew York$3.9M
Todd AlbertNew York$2.7M
Jeffrey SpivakNew York$1.3M
Aaron BucklandNew York$1M
Seth NeubardtWhite Plains$902K
Sheeraz QureshiNew York$828K
Jeffrey GoldsteinNew York$765K
Fabien BitanNew York$624K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →